HC Wainwright Issues Optimistic Estimate for PRLD Earnings
Prelude Therapeutics Incorporated (NASDAQ:PRLD – Free Report) – Research analysts at HC Wainwright upped their Q2 2025 earnings estimates for Prelude Therapeutics in a report issued on Wednesday, May 7th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($0.43) per share for the quarter, up from their previous forecast […]
Prelude Therapeutics Incorporated (NASDAQ:PRLD – Free Report) – Research analysts at HC Wainwright upped their Q2 2025 earnings estimates for Prelude Therapeutics in a report issued on Wednesday, May 7th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($0.43) per share for the quarter, up from their previous forecast […]
